%0 Journal Article
%T Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis
%A Health Quality Ontario
%J Archive of "Ontario Health Technology Assessment Series".
%D 2016
%X Major depressive disorder (MDD, 10% over a person's lifetime) is common and costly to the health system. Unfortunately, many MDD cases are resistant to treatment with antidepressant drugs and require other treatment to reduce or eliminate depression. Electroconvulsive therapy (ECT) has long been used to treat persons with treatment-resistant depression (TRD). Despite its effectiveness, ECT has side effects that make patients intolerant to the treatment, or they refuse to use it. Repetitive transcranial magnetic stimulation (rTMS), which has fewer side effects than ECT and might be an alternative for TRD patients who are ineligible for or unwilling to undergo ECT, has been developed to treat TRD
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808718/